In 2022 the company made a revenue of $9.43 M a decrease over the years 2021 revenue that were of $18.43 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | -100% |
2022 | $9.43 M | -48.83% |
2021 | $18.43 M | -42.68% |
2020 | $32.16 M | 371.02% |
2019 | $6.82 M | |
2018 | N/A | -100% |
2017 | $0.31 M | -82.75% |
2016 | $1.8 M | -88.43% |
2015 | $15.57 M | -45.09% |
2014 | $28.37 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Coherus BioSciences
CHRS | $0.25 B | N/A | ๐บ๐ธ USA |
Atara Biotherapeutics ATRA | $8.57 M | N/A | ๐บ๐ธ USA |